Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Germline Pharmacogenetic Studies-Reference-Cited by-同舟云学术

Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Germline Pharmacogenetic Studies

Published:2014-12-08 Issue:2 Volume:107 Page:
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Goetz Matthew P.,Sun James X.,Suman Vera J.,Silva Grace O.,Perou Charles M.,Nakamura Yusuke,Cox Nancy J.,Stephens Philip J.,Miller Vincent A.,Ross Jeffrey S.,Chen David,Safgren Stephanie L.,Kuffel Mary J.,Ames Matthew M.,Kalari Krishna R.,Gomez Henry L.,Gonzalez-Angulo Ana M.,Burgues Octavio,Brauch Hiltrud B.,Ingle James N.,Ratain Mark J.,Yelensky Roman

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/107/2/dju401/17313897/dju401.pdf

Reference28 articles.

1. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine;Stearns;J Natl Cancer Inst,2003

2. Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma;Murdter;Clin Pharmacol Ther,2011

3. Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer;Brauch;Br J Clin Pharmacol,2014

4. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes;Goetz;J Clin Oncol,2005

5. CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients;Rae;J Natl Cancer Inst,2012

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonlinear Mixed‐Effects Model of Z‐Endoxifen Concentrations in Tamoxifen‐Treated Patients from the CEPAM Cohort;Clinical Pharmacology & Therapeutics;2024-03-18

2. Influence of CYP2D6 and its polymorphic forms on the metabolism of tamoxifen in therapy of luminal forms of breast cancer;Reports of Vinnytsia National Medical University;2024-03-14

3. Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients;The Pharmacogenomics Journal;2023-01-28

4. Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark;Breast Cancer Research and Treatment;2022-04-30

5. Planning and Conducting a Pharmacogenetics Association Study;Clinical Pharmacology & Therapeutics;2021-06-19